These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 4208360)

  • 21. [Therapeutic results of betahistine on Meniere's disease. Multi-variable analysis of the results of the double blind test and Fisher's evaluation method].
    Okamoto K; Hazeyama F; Taira T; Yoshida A; Onoda T
    Iryo; 1968 May; 22(5):650-66. PubMed ID: 4972506
    [No Abstract]   [Full Text] [Related]  

  • 22. A controlled study on the effect of pentoxifylline and an ergot alkaloid derivative on regional cerebral blood flow in patients with chronic cerebrovascular disease.
    Hartmann A; Tsuda Y
    Angiology; 1988 May; 39(5):449-57. PubMed ID: 3288016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evaluation of the effect of betahistine in Meniere's disease by double-blind test and multivariate analysis].
    Watanabe K; Fukami J; Yoshimoto H; Ueda M; Suzuki J
    Jibiinkoka; 1967 Nov; 39(11):1237-50. PubMed ID: 4969849
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of intravenous infusion of glycerol on regional cerebral blood flow in cerebral infarction.
    Antonini FM; Bertini G; Fumagalli C; Fieschi C; Battistini N; Violante F; Nori A
    Gerontology; 1977; 23(5):376-80. PubMed ID: 852665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Preliminary results in the modifications of cerebral blood flow using xenon-133 during administration of ginkgo-biloba].
    Agnoli A; Fiorani P; Pistolese GR
    Minerva Med; 1973 Nov; 64(79 Suppl):4166-73. PubMed ID: 4378392
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of hexobendine on cerebral hemispheric blood flow and metabolism. Preliminary clinical observations concerning its use in ischemic cerebrovascular disease.
    Meyer JS; Kanda T; Shinohara Y; Fukuuchi Y; Shimazu K; Ericsson AD; Gordon WH
    Neurology; 1971 Jul; 21(7):691-702. PubMed ID: 5105507
    [No Abstract]   [Full Text] [Related]  

  • 27. Rheoencephalographic and other studies of betahistine in humans: I. The cerebral and peripheral circulatory effects of single doses in normal subjects.
    Seipel JH; Floam JE
    J Clin Pharmacol; 1975; 15(2-3):144-54. PubMed ID: 1123455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Use of betahistine in ear diseases, especially equilibrium disturbance, with special reference to its action mechanism].
    Mishima K
    Jibiinkoka; 1970 May; 42(5):397-402. PubMed ID: 4988663
    [No Abstract]   [Full Text] [Related]  

  • 29. The effects of betahistine on the isolated perfused baboon kidney.
    Groenewald JH; Retief CP; Murphy GP
    S Afr Med J; 1970 Sep; 44(35):1002-5. PubMed ID: 4990314
    [No Abstract]   [Full Text] [Related]  

  • 30. Regional cerebral blood flow and cariovascular effects of hexobendine in stroke patients.
    McHenry LC; West JW; KEnton EJ; Oshiro T; Jaffe ME; Cooper ES; Kawamura J; Goldberg HI
    Neurology; 1972 Mar; 22(3):217-23. PubMed ID: 5062256
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment of endolymphatic edema with betahistine hydrochloride].
    Bosch J
    Acta Otorinolaryngol Iber Am; 1970; 21(3):325-30. PubMed ID: 4994506
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of cyclandelate on cerebral cortex perfusion-rates in cerebrovascular disease.
    O'Brien MD; Veall N
    Lancet; 1966 Oct; 2(7466):729-30. PubMed ID: 4162060
    [No Abstract]   [Full Text] [Related]  

  • 33. Betahistine HCL antagonism upon neural influence on microcirculation.
    Baez S; Gootman PM; Feldman SM; Orkin LR
    Bibl Anat; 1973; 12():437-42. PubMed ID: 4208230
    [No Abstract]   [Full Text] [Related]  

  • 34. The role of betahistine hydrochloride in the treatment of peripheral vascular arterial disease.
    Allison RD; Barnes RN
    Tex Med; 1971 Nov; 67(11):85-92. PubMed ID: 5001167
    [No Abstract]   [Full Text] [Related]  

  • 35. [The new cerebrovascular preparation pikamilon].
    Mirzoian RS; Gan'shina TS
    Farmakol Toksikol; 1989; 52(1):23-6. PubMed ID: 2707413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rheoencephalographic and other studies of betahistine in humans: II. The crerbral and peripheral microcirculatory effects of single doses in geriatric patients with "pure" arteriosclerotic dementia.
    Seipel JH; Fisher R; Floam JE; Bohm M
    J Clin Pharmacol; 1975; 15(2-3):155-62. PubMed ID: 1123456
    [No Abstract]   [Full Text] [Related]  

  • 37. [Initial findings in the treatment of Meniere's disease with betahistine hydrochloride (Betaserc)].
    Segers JM
    Acta Otorhinolaryngol Belg; 1972; 26(2):262-8. PubMed ID: 4626970
    [No Abstract]   [Full Text] [Related]  

  • 38. Long-term office treatment of Meniere's disease.
    Martins JK
    Eye Ear Nose Throat Mon; 1969 Jul; 48(7):410-2. PubMed ID: 4978414
    [No Abstract]   [Full Text] [Related]  

  • 39. Vasodilators in menière's syndrome.
    Piercy NM
    Br Med J; 1971 Oct; 4(5782):303. PubMed ID: 5001332
    [No Abstract]   [Full Text] [Related]  

  • 40. The effect of betahistine hydrochloride in Méniére's disease.
    Wilmot TJ
    Acta Otolaryngol Suppl; 1972; 305():18-21. PubMed ID: 4353748
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.